Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | +0.61% | +9.96% | -11.96% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 337.6 | 219.5 | 209.1 | 184.6 | - | - |
Enterprise Value (EV) 1 | 337.6 | 219.5 | 209.1 | 184.6 | 184.6 | 184.6 |
P/E ratio | - | - | - | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | 2,462 x | 134 x | 9.17 x |
EV / Revenue | - | - | - | 2,462 x | 134 x | 9.17 x |
EV / EBITDA | - | -7.04 x | -6.04 x | -4.06 x | -3.26 x | -6.94 x |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 34,375 | 69,012 | 69,474 | 69,671 | - | - |
Reference price 2 | 9.820 | 3.180 | 3.010 | 2.650 | 2.650 | 2.650 |
Announcement Date | 22-03-28 | 23-03-09 | 24-03-07 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | - | - | 0.075 | 1.373 | 20.13 |
EBITDA 1 | - | -31.16 | -34.61 | -45.49 | -56.58 | -26.6 |
EBIT 1 | -13.79 | -32.14 | -35.68 | -41.42 | -52.13 | -46.9 |
Operating Margin | - | - | - | -55,220.48% | -3,795.87% | -232.96% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - |
EPS | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 22-03-28 | 23-03-09 | 24-03-07 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | 0.025 | 0.05 | 0.3 |
EBITDA 1 | - | - | - | - | - | - | - | - | -10.14 | -10.7 | -11.34 | -12.08 | - |
EBIT 1 | -8.781 | -8.012 | -7.358 | -7.985 | -8.644 | -8.168 | -7.339 | -9.943 | -9.814 | -9.838 | -10.49 | -11.27 | -11.78 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | -41,943.32% | -22,549.72% | -3,928% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-05-26 | 22-08-25 | 22-11-22 | 23-03-09 | 23-05-23 | 23-08-28 | 23-11-16 | 24-03-07 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | -95.3% | - | -45.8% | -44.2% | -8.72% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | 2.93 | 0.9 | - | 4 | 6 | - |
Capex / Sales | - | - | - | 5,333.33% | 436.89% | - |
Announcement Date | 22-03-28 | 23-03-09 | 24-03-07 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.96% | 185M | |
+2.10% | 982M | |
+41.91% | 872M | |
+23.30% | 806M | |
+1.74% | 664M | |
+4.13% | 642M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M | |
-18.56% | 470M |
- Stock Market
- Equities
- DRTS Stock
- Financials Alpha Tau Medical Ltd.